Oscillospira - a candidate for the next-generation probiotics

Oscillospira is a class of organism that often appears in high-throughput sequencing data but has not been purely cultured and is widely present in the animal and human intestines. There is a strong association between variation in Oscillospira abundance and obesity, leanness, and human health. In a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jingpeng Yang, Yanan Li, Zhiqiang Wen, Wenzheng Liu, Lingtong Meng, He Huang
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2021
Materias:	oscillospira obesity human health short-chain fatty acids (scfas) next-generation probiotics Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/789a3ca4bf174bc3afebfb49e32db5fc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:789a3ca4bf174bc3afebfb49e32db5fc
record_format	dspace
spelling	oai:doaj.org-article:789a3ca4bf174bc3afebfb49e32db5fc2021-11-04T15:00:42ZOscillospira - a candidate for the next-generation probiotics1949-09761949-098410.1080/19490976.2021.1987783https://doaj.org/article/789a3ca4bf174bc3afebfb49e32db5fc2021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/19490976.2021.1987783https://doaj.org/toc/1949-0976https://doaj.org/toc/1949-0984Oscillospira is a class of organism that often appears in high-throughput sequencing data but has not been purely cultured and is widely present in the animal and human intestines. There is a strong association between variation in Oscillospira abundance and obesity, leanness, and human health. In addition, a growing body of studies has shown that Oscillospira is also implicated in other diseases, such as gallstones and chronic constipation, and has shown some correlation with the positive or negative changes in its course. Sequencing data combined with metabolic profiling indicate that Oscillospira is likely to be a genus capable of producing short-chain fatty acids (SCFAs) such as butyrate, which is an important reference indicator for screening “next-generation probiotics “. Considering the positive effects of Oscillospira in some specific diseases, such as obesity-related metabolic diseases, it has already been characterized as one of the next-generation probiotic candidates and therefore has great potential for development and application in the future food, health care, and biopharmaceutical products.Jingpeng YangYanan LiZhiqiang WenWenzheng LiuLingtong MengHe HuangTaylor & Francis Grouparticleoscillospiraobesityhuman healthshort-chain fatty acids (scfas)next-generation probioticsDiseases of the digestive system. GastroenterologyRC799-869ENGut Microbes, Vol 13, Iss 1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	oscillospira obesity human health short-chain fatty acids (scfas) next-generation probiotics Diseases of the digestive system. Gastroenterology RC799-869
spellingShingle	oscillospira obesity human health short-chain fatty acids (scfas) next-generation probiotics Diseases of the digestive system. Gastroenterology RC799-869 Jingpeng Yang Yanan Li Zhiqiang Wen Wenzheng Liu Lingtong Meng He Huang Oscillospira - a candidate for the next-generation probiotics
description	Oscillospira is a class of organism that often appears in high-throughput sequencing data but has not been purely cultured and is widely present in the animal and human intestines. There is a strong association between variation in Oscillospira abundance and obesity, leanness, and human health. In addition, a growing body of studies has shown that Oscillospira is also implicated in other diseases, such as gallstones and chronic constipation, and has shown some correlation with the positive or negative changes in its course. Sequencing data combined with metabolic profiling indicate that Oscillospira is likely to be a genus capable of producing short-chain fatty acids (SCFAs) such as butyrate, which is an important reference indicator for screening “next-generation probiotics “. Considering the positive effects of Oscillospira in some specific diseases, such as obesity-related metabolic diseases, it has already been characterized as one of the next-generation probiotic candidates and therefore has great potential for development and application in the future food, health care, and biopharmaceutical products.
format	article
author	Jingpeng Yang Yanan Li Zhiqiang Wen Wenzheng Liu Lingtong Meng He Huang
author_facet	Jingpeng Yang Yanan Li Zhiqiang Wen Wenzheng Liu Lingtong Meng He Huang
author_sort	Jingpeng Yang
title	Oscillospira - a candidate for the next-generation probiotics
title_short	Oscillospira - a candidate for the next-generation probiotics
title_full	Oscillospira - a candidate for the next-generation probiotics
title_fullStr	Oscillospira - a candidate for the next-generation probiotics
title_full_unstemmed	Oscillospira - a candidate for the next-generation probiotics
title_sort	oscillospira - a candidate for the next-generation probiotics
publisher	Taylor & Francis Group
publishDate	2021
url	https://doaj.org/article/789a3ca4bf174bc3afebfb49e32db5fc
work_keys_str_mv	AT jingpengyang oscillospiraacandidateforthenextgenerationprobiotics AT yananli oscillospiraacandidateforthenextgenerationprobiotics AT zhiqiangwen oscillospiraacandidateforthenextgenerationprobiotics AT wenzhengliu oscillospiraacandidateforthenextgenerationprobiotics AT lingtongmeng oscillospiraacandidateforthenextgenerationprobiotics AT hehuang oscillospiraacandidateforthenextgenerationprobiotics
_version_	1718444778909073408

Oscillospira - a candidate for the next-generation probiotics

Ejemplares similares